Marksans Pharma Ltd Share Price History
₹ 3.2 Cr
Volume Transacted
(Nov 22, 2024)
104.3 K
Stocks Traded
(Nov 22, 2024)
Last Updated on: Nov 23, 2024
Marksans Pharma Ltd
BSE
22 Nov, 2024
308.55-0.4 (-0.1%)
Prev Close
309
Open Price
311.45
Bid Price (QTY)
Offer Price (QTY)
Volume
104309
Today's High / Low
319.0 / 306.6
52 WK High / Low
328.4 / 126.1
NSE
22 Nov, 2024
308.65-0.5 (-0.2%)
Prev Close
309.15
Open Price
310
Bid Price (QTY)
Offer Price (QTY)
Volume
1946126
Today's High / Low
319.2 / 306.0
52 WK High / Low
328.8 / 130.0
×
PRICE
The current market price or CMP refers to the price at which the securities are trading in the share market. Current price in Over-the-counter costs: The following current price depends upon the bid price & the asking price when a financial asset is sold over-the-counter(OTC). Current Price in Bond Market: The current price of a bond is determined by measuring the actual interest rate against the bid-related interest rate. The par or the face value is then calculated to represent the remaining interest payments due which occur before the maturity of the bond.
Market Price of Marksans Pharma Ltd
1M
1Y
3Y
5Y
To make informed investment decisions, regularly checking Marksans Pharma Ltd share price can be a beneficial practice. *All values are in Rupees.
Last Ten Days Market Price
| Date | Price (₹) | Day Open (₹) | Day High (₹) | Day Low (₹) |
|---|
| 22 Nov 2024 | 308.55 | 311.45 | 319 | 306.65 |
| 21 Nov 2024 | 309 | 300.05 | 310 | 297.25 |
| 19 Nov 2024 | 305.85 | 312.2 | 314.25 | 303 |
| 18 Nov 2024 | 309.3 | 312.8 | 316 | 303.95 |
| 14 Nov 2024 | 307.35 | 307.95 | 324.9 | 304.65 |
| 13 Nov 2024 | 305.55 | 301 | 318 | 298.3 |
| 12 Nov 2024 | 300.35 | 286 | 311 | 286 |
| 11 Nov 2024 | 289 | 298.1 | 298.3 | 284.7 |
| 08 Nov 2024 | 298.6 | 302.95 | 309.8 | 293.55 |
| 07 Nov 2024 | 301.35 | 298.95 | 305.5 | 292.75 |
| Date |  Price (₹) |
|---|---|
| 22 Nov 2024 | 308.55 |
| 21 Nov 2024 | 309 |
| 19 Nov 2024 | 305.85 |
| 18 Nov 2024 | 309.3 |
| 14 Nov 2024 | 307.35 |
| 13 Nov 2024 | 305.55 |
| 12 Nov 2024 | 300.35 |
| 11 Nov 2024 | 289 |
| 08 Nov 2024 | 298.6 |
| 07 Nov 2024 | 301.35 |
Returns Comparison Table
| Entity | 1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | 10Y |
|---|
| Cipla Ltd | 1.4 | -1.6 | -6.3 | 0.3 | 16.9 | 66.1 | 210.6 | 140.5 |
| Marksans Pharma Ltd | -0.2 | 16.1 | 34.1 | 85.0 | 121.2 | 470.9 | 1977.8 | 396.5 |
| Torrent Pharmaceuticals Ltd | 2.1 | -5.0 | -5.7 | 18.9 | 50.0 | 130.2 | 270.4 | 527.5 |
| Sun Pharmaceuticals Industries Ltd | 2.9 | -4.7 | 2.7 | 16.7 | 49.3 | 133.3 | 297.7 | 114.8 |
| Divis Laboratories Ltd | 4.1 | 3.1 | 22.2 | 47.7 | 62.1 | 28.2 | 246.0 | 596.5 |
| Mankind Pharma Ltd | -1.9 | -0.6 | 9.9 | 21.1 | 31.9 | 0.0 | 0.0 | 0.0 |
| Entity | 1W |
|---|---|
| Cipla Ltd | 1.4 |
| Marksans Pharma Ltd | -0.2 |
| Torrent Pharmaceuticals Ltd | 2.1 |
| Sun Pharmaceuticals Industries Ltd | 2.9 |
| Divis Laboratories Ltd | 4.1 |
| Mankind Pharma Ltd | -1.9 |
Last updated time: 23 Nov 9.00 AM
Growth Parameters
| Parameter | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|
| Sales | 767 | 913 | 1000 | 1134 | 1376 | 1491 | 1852 | 2177 |
| Sales YoY Gr. | - | 19.0% | 9.6% | 13.4% | 21.3% | 8.3% | 24.2% | 17.6% |
| Adj EPS | 0 | 0.87 | 1.97 | 2.95 | 5.83 | 4.56 | 5.85 | 6.95 |
| YoY Gr. | - | 87.0% | 126.4% | 49.8% | 97.6% | -21.8% | 28.3% | 18.8% |
| Adj Net Profit | 11 | 36 | 80 | 121 | 239 | 187 | 265 | 315 |
| BVPS | 10.59 | 11.5 | 13.25 | 15.54 | 21.66 | 27.1 | 38.51 | 45.57 |
| Parameter | 2017 |
|---|---|
| Sales | 767 |
| Sales YoY Gr. | - |
| Adj EPS | 0 |
| YoY Gr. | - |
| Adj Net Profit | 11 |
| BVPS | 10.59 |
Key Financial Parameters
| Parameter | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|
| Return on Capital Emp. % | 29.22 | 18.64 | 3.36 | 9.08 | 17.23 | 25.02 | 38.77 | 22.83 | 21.77 | 20.78 |
| Op. Profit Mgn % | 23.61 | 16.25 | 6.75 | 9.52 | 13.68 | 16.98 | 25.16 | 20.17 | 21.52 | 23.38 |
| Net Profit Mgn % | 14.05 | 9.26 | 1.48 | 3.92 | 8.04 | 10.65 | 17.33 | 12.53 | 14.33 | 14.46 |
| Debt to Equity % | 0.48 | 0.21 | 0.22 | 0.25 | 0.22 | 0.11 | 0.04 | 0.07 | 0.08 | 0.1 |
| Parameter | 2015 |
|---|---|
| Return on Capital Emp. % | 29.22 |
| Op. Profit Mgn % | 23.61 |
| Net Profit Mgn % | 14.05 |
| Debt to Equity % | 0.48 |
FAQs for Marksans Pharma Ltd Share Price History
What are the key events that typically impact Marksans Pharma Ltd's share price history?
Key events that impact Marksans Pharma Ltd’s share price history include quarterly earnings releases, product launches, leadership changes, economic policies, and geopolitical developments.
How do stock splits affect Marksans Pharma Ltd's share price history?
Stock splits reduce the nominal price of Marksans Pharma Ltd's shares by increasing the number of outstanding shares, which typically makes the stock more accessible to a broader range of investors. Although the total market value of the company remains unchanged after the split, the split can affect investor perception and liquidity, potentially influencing the share price in the longer term.
How do dividends impact the share price history of Marksans Pharma Ltd?
Dividends can influence Marksans Pharma Ltd's share price history by typically causing a temporary dip on the ex-dividend date, as the stock price often adjusts to reflect the dividend payout. Over time, the impact of dividends on the share price may be offset by the company's overall financial performance and market conditions.
How do corporate announcements affect Marksans Pharma Ltd’s share price history?
Corporate announcements such as mergers, acquisitions, or strategic shifts can lead to significant price changes. Any optimistic development news on Marksans Pharma Ltd generally boosts the company’s share price, whereas negative news can lead to a decline in share price.
How can I use technical analysis to understand Marksans Pharma Ltd’s share price history?
To understand Marksans Pharma Ltd’s share price history using technical analysis, examine charts for patterns such as trends, support, and resistance levels, and apply indicators like moving averages or Relative Strength Index (RSI) to gauge potential future movements. Analyze historical data to identify recurring trends and signals that might suggest how the share price could behave under similar conditions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Unlimited trading at just
Rs. 199*